Search research articles
Contact Us
Filters
Showing results (21-30 of 52) with videos related to
Page
of 6
Sort By:
International Journal of Molecular Sciences
|
May 20, 2020
Dynamic Changes of Heart Failure Biomarkers in Response to Parabolic Flight
Peter Jirak, Bernhard Wernly, Michael Lichtenauer, et al.
Journal of Electrocardiology
|
May 31, 2019
Potential mechanisms of endothelialisation in individuals implanted with a leadless pacemaker systems: An experimental in vitro study
Christoph Edlinger, Vera Paar, Thomas Tuscher, et al.
Acta Pharmacologica Sinica
|
December 15, 2017
Influences of Ivabradine treatment on serum levels of cardiac biomarkers sST2, GDF-15, suPAR and H-FABP in patients with chronic heart failure
Peter Jirak, Dzeneta Fejzic, Vera Paar, et al.
Heart, Lung & Circulation
|
July 23, 2019
Analysis of Novel Cardiovascular Biomarkers in Patients With Pulmonary Hypertension (PH)
Moritz Mirna, Ilonka Rohm, Peter Jirak, et al.
Advances in Clinical Chemistry
|
February 25, 2019
Clinical implications of fetuin-A
Peter Jirak, Lars Stechemesser, Elena Moré, et al.
Minerva Medica
|
April 14, 2018
Analysis of novel cardiovascular biomarkers in patients with peripheral artery disease
Peter Jirak, Moritz Mirna, Bernhard Wernly, et al.
European Journal of Clinical Investigation
|
December 31, 2016
Soluble ST2 predicts 1-year outcome in patients undergoing transcatheter aortic valve implantation
Bernhard Wernly, Michael Lichtenauer, Peter Jirak, et al.
Minerva Medica
|
July 13, 2022
Main pulmonary artery diameter in combination with cardiovascular biomarkers: new possibilities to identify pulmonary hypertension in patients with severe aortic valve stenosis
Elke Boxhammer, Vera Paar, Peter Jirak, et al.
Journal of Clinical Medicine
|
August 28, 2025
Dynamics of the Novel Cardiac Biomarkers sST2, H-FABP, GDF-15 and suPAR in HFrEF Patients Undergoing Heart Failure Therapy, a Pilot Study
Bernhard Ohnewein, Zornitsa Shomanova, Peter Jirak, et al.
European Journal of Internal Medicine
|
November 16, 2020
Serum levels of C-terminal FGF23 (cFGF23) are associated with 1-year-mortality in patients undergoing transcatheter aortic valve replacement (TAVR)
Moritz Mirna, Alexander Lauten, Peter Jirak, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 52) with videos related to
Sort By:
Page
of 6
International Journal of Molecular Sciences
|
May 20, 2020
Dynamic Changes of Heart Failure Biomarkers in Response to Parabolic Flight
Peter Jirak, Bernhard Wernly, Michael Lichtenauer, et al.
Journal of Electrocardiology
|
May 31, 2019
Potential mechanisms of endothelialisation in individuals implanted with a leadless pacemaker systems: An experimental in vitro study
Christoph Edlinger, Vera Paar, Thomas Tuscher, et al.
Acta Pharmacologica Sinica
|
December 15, 2017
Influences of Ivabradine treatment on serum levels of cardiac biomarkers sST2, GDF-15, suPAR and H-FABP in patients with chronic heart failure
Peter Jirak, Dzeneta Fejzic, Vera Paar, et al.
Heart, Lung & Circulation
|
July 23, 2019
Analysis of Novel Cardiovascular Biomarkers in Patients With Pulmonary Hypertension (PH)
Moritz Mirna, Ilonka Rohm, Peter Jirak, et al.
Advances in Clinical Chemistry
|
February 25, 2019
Clinical implications of fetuin-A
Peter Jirak, Lars Stechemesser, Elena Moré, et al.
Minerva Medica
|
April 14, 2018
Analysis of novel cardiovascular biomarkers in patients with peripheral artery disease
Peter Jirak, Moritz Mirna, Bernhard Wernly, et al.
European Journal of Clinical Investigation
|
December 31, 2016
Soluble ST2 predicts 1-year outcome in patients undergoing transcatheter aortic valve implantation
Bernhard Wernly, Michael Lichtenauer, Peter Jirak, et al.
Minerva Medica
|
July 13, 2022
Main pulmonary artery diameter in combination with cardiovascular biomarkers: new possibilities to identify pulmonary hypertension in patients with severe aortic valve stenosis
Elke Boxhammer, Vera Paar, Peter Jirak, et al.
Journal of Clinical Medicine
|
August 28, 2025
Dynamics of the Novel Cardiac Biomarkers sST2, H-FABP, GDF-15 and suPAR in HFrEF Patients Undergoing Heart Failure Therapy, a Pilot Study
Bernhard Ohnewein, Zornitsa Shomanova, Peter Jirak, et al.
European Journal of Internal Medicine
|
November 16, 2020
Serum levels of C-terminal FGF23 (cFGF23) are associated with 1-year-mortality in patients undergoing transcatheter aortic valve replacement (TAVR)
Moritz Mirna, Alexander Lauten, Peter Jirak, et al.
Page
of 6